Direct determination of verapamil in urine and serum samples by micellar liquid chromatography and fluorescence detection

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 839, Issue 1-2, 2006, Pages 89-94

  Rambla Alegre, M ^a   Gil Agusti M T ^a   Capella Peiro M E ^a   Carda Broch, S ^a   Esteve Romero, J S ^a  

^a ESTCE ^*  (Spain)

Author keywords

Direct injection; Micellar mobile phase; Serum; Urine; Verapamil

Indexed keywords

CALCIUM COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; FLUORESCENCE; METABOLITES; MICELLES; PROTEINS; SODIUM COMPOUNDS;

DIRECT INJECTION; MICELLAR MOBILE PHASE; SERUM; URINE; VERAPAMIL;

DRUG PRODUCTS;

CALCIUM CHANNEL BLOCKING AGENT; DODECYL SULFATE SODIUM; PENTANOL; TRANDOLAPRIL PLUS VERAPAMIL; VERAPAMIL;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG EXCRETION; DRUG URINE LEVEL; ELUTION; FLUORESCENCE; HUMAN; HYPERTENSION; LIVER METABOLISM; MICELLAR LIQUID CHROMATOGRAPHY; OBSERVER VARIATION; PH; PRIORITY JOURNAL; TREATMENT OUTCOME; VALIDATION PROCESS;

CALIBRATION; CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY; FLUORESCENCE; HUMANS; REPRODUCIBILITY OF RESULTS; VERAPAMIL;

EID: 33745935362     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.03.054     Document Type: Article

References (20)

1. Bergström C.A.S., Luthman K., and Arturson P. Eur. J. Pharm. Sci. 22 (2004) 387
2. American Hospital Formulary Service, Drug Information, American Society of Health-System Pharmacists, Bethesda, MD, 1988.
3. Kirsten R., Nelson K., Kirsten D., and Heintz B. Clin. Pharmacokinet. 34 (1998) 457
4. Gupta S.K., Hwang S., Atkinson I., and Longstreth J. J. Clin. Pharmacol. 36 (1996) 25
5. Musshoff F., Padosch S., Steinborn S., and Madea B. Forensic Sci. Int. 142 (2004) 161
6. Gay R., Algeo S., Lee R., Olajos M., Morkin E., and Goldman S. J. Clin. Invest. 77 (1986) 1805
7. Brandsteterová E., and Wainer I.W. J. Chromatogr. B 732 (1999) 395
8. Sawicki W. Eur. J. Pharm. Biopharm. 53 (2002) 29
9. Sawicki W., and Janicki S. Int. J. Pharm. 238 (2002) 181
10. Sawicki W. J. Pharm. Biomed. Anal. 25 (2001) 689
11. Walles M., Mullett W.M., Levsen K., Borlak J., Wünsch G., and Pawliszyn J. J. Pharm. Biomed. Anal. 30 (2002) 307
12. Jhee O.H., Hong J.W., Om A.S., Lee M.H., Lee W.S., Shaw L.M., Lee J.W., and Kang J.S. J. Pharm. Biomed. Anal. 37 (2005) 405
13. Kinoshita H., Taniguchi T., Nishiguchi M., Ouchi H., Minami T., Utsumi T., Motomura H., Tsuda T., Ohta T., Aoki S., et al. Forensic Sci. Int. 133 (2003) 107
14. Hofer C.A., Smith J.K., and Tenholder M.F. Am. J. Med. 95 (1993) 431
15. Immonen P., Linkola A., and Waris E. Int. J. Cardiol. 1 (1981) 101
16. Esteve Romero J., Carda Broch S., Gil Agustí M., Capella-Peiró M.E., and Bose D. Trends Anal. Chem. 24 (2005) 75
17. Gil-Agusti M., Capella-Peiro M.E., Martinavarro-Dominguez A., and Esteve-Romero J. Chromatographia 57 (2003) 51
18. Capella-Peiro M.E., Gil-Agusti M., Martinavarro-Dominguez A., and Esteve-Romero J. Anal. Biochem. 309 (2002) 261
19. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001 BP, website: http://www.fda-gov/ceder/guidance/index.htm.
20. Torres-Lapasio J.R., Baeza-Baeza J.J., and Garcia-Alvarez-Coque M.C. Anal. Chem. 69 (1997) 3822